Introduction {#s1}
============

Membrane transporters play an important role in the disposition of many drug molecules, especially the electrochemically charged cationic and anionic drug moieties. ATP-binding cassette (ABC) and solute carrier (SLC) transporters are two major superfamilies of drug transporters. Multidrug and toxin extrusion (MATE) proteins are involved in the efflux of certain lipophobic organic cations such as metformin (biguanide), cimetidine (H~2~ receptor blocker), and topotecan (camptothecin analog). MATEs are secondary active transporters acquiring energy from the oppositely directed proton gradient, also entitled as H^+^/organic cation antiporters (electroneutral transport). MATE transporters are made up of 400 to 550 amino acid residues spanning 12 transmembrane domains.^[@R1],[@R2]^

*SLC47A1* and *SLC47A2* are the genes coding for the transporters MATE1 and MATE2/ 2-K, respectively. Both these genes are positioned in tandem on the short arm of the 17th chromosome, i.e., at 17p11.2. MATE1 and MATE2 are also designated as SLC47A1 and SLC47A2, respectively; where SLC is the superfamily, the adjacent two digits denote the family (or) subclass and the suffixed alpha-numeral accounts for the specific transporter.^[@R3]^

Other known substrates/inhibitors of MATE are acyclovir, cisplatin, ganciclovir, procainamide, clonidine, ranitidine, imatinib and zafirlukast (non-selective); cephalexin, cephradine, levofloxacin, fexofenadine, tenofovir, imipramine and vecuronium (MATE1 selective); verapamil, oxaliplatin and pramipexole (MATE2 selective).^[@R4],[@R5]^ However, of all the known substrates the pharmacokinetic and pharmacodynamic properties of the anti-diabetic drug metformin is greatly influenced by the functioning of these MATE transporters. MATE1, present at the canalicular (luminal) surface of hepatocytes, is involved in the hepatic biliary excretion of metformin. Similarly, MATE1 and MATE2 expressed at the apical (luminal) side of the renal tubules help in renal elimination of metformin through the urine.

Genetic variation in the genes coding for MATE1 and MATE2 have been found to be associated with an altered glycemic response to metformin.^[@R6]-[@R8]^ As current knowledge in this field is inadequate and sometimes inconsistent, additional studies were required to confirm the clinical relevance of single nucleotide polymorphisms (SNPs) in genes coding for these transporters. Hence, this study was set forth to assess the prevalence of genetic polymorphisms of MATE1 and MATE2 transporter proteins in healthy population of South India who had a distinct genetic makeup. The SNP rs2289669 in the intronic region (922-158G\>A) of *SLC47A1* gene and the SNP rs12943590 in the 5ʹUTR region (-130G\>A) of *SLC47A2* gene were the polymorphisms proposed to be studied ([Fig. S1](#S1){ref-type="supplementary-material"}).

Materials and methods {#s2}
=====================

Subjects {#s2-0-1}
--------

The study was performed on 102 unrelated healthy volunteers hailing from Southern states of India (Tamil Nadu, Andhra Pradesh, Karnataka or Kerala). All these subjects were living in the South Indian states for at least three consecutive generations and speaking the native languages (Tamil, Telugu, Kannada or Malayalam). Out of 102 volunteers, 69 (67.6%) were males and 33 (32.4%) were females; and the mean age (± SD) was 28.7±9.4 years.

Under sterile precautions, 5 mL of venous blood was collected in a polypropylene centrifuge tube (15 mL) containing 100 μL of 10% disodium ethylenediaminetetraacetic acid salt (anti-coagulant) from each of the participants for genotyping. The samples were subsequently centrifuged at 2500 rpm for 10 minutes at 4°C. The supernatant containing plasma was discarded and the lower cellular fraction was stored at -80°C until further processing. Cellular fraction of the blood was used for DNA extraction and genotyping of *SLC47A1* and *SLC47A2* gene polymorphisms.

Genomic DNA was extracted from the frozen stored cellular fraction of the blood (i.e., from the peripheral white blood corpuscles) by using standardized 'phenol-chloroform extraction method'. Multi-analyzer (Tecan Infinite M200, Switzerland) was utilized to determine the quality and quantity of the extracted DNA. The DNA samples were diluted to a concentration of 50 ng/μL by adding autoclaved DNase-free MilliQ water and were stored at -80°C until genotyping. Genotyping for SNPs rs2289669 in *SLC47A1* gene and rs12943590 in *SLC47A2* gene was performed using Applied Biosystems 7300 Real-Time PCR System (ABI, Foster City, CA, USA) using validated TaqMan^®^ SNP genotyping assay method ([Table 1](#T1){ref-type="table"}).

###### Characteristic features of genetic polymorphisms studied

  ----------- ---------------------- ------------------- ------------------ ------------ -------------------
  **Gene**    **Base pair change**   **Gene location**   **SNP location**   **rs ID**    **Assay ID**
  *SLC47A1*   922-158G\>A            17p11.2             intron             rs2289669    C\_\_1588280_10
  *SLC47A2*   -130G\>A               17p11.2             5'UTR              rs12943590   C\_\_\_2593951_10
  ----------- ---------------------- ------------------- ------------------ ------------ -------------------

The diluted DNA samples were incubated at 37°C for 24 hours before subjecting to qRT-PCR. The PCR reaction was carried out using 10 μL of final volume that contained 5 μL of TaqMan^®^ Universal PCR Master Mix (2x), 0.25 μL of 40x working stock of TaqMan^®^ assay, 2.5 μL of 50 ng/μL diluted genomic DNA and 2.25 μL of deionized water. The thermocycler conditions are given in [Table 2](#T2){ref-type="table"}. [Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} depict the amplification plots of the SNPs.
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###### Quantitative real-time PCR thermal cycling conditions

  ------------------------- -------------------- ------------------- ----
  **Steps**                 **PCR conditions**   **No. of cycles**   
  **Temperature**           **Time**                                 
  Initial denaturation      60°C                 2 min               1
  Amplification             95°C                 10 min              1
  Denaturation              92.5°C               15 s                45
  Annealing and extension   60°C                 1 min               45
  ------------------------- -------------------- ------------------- ----

Allelic discrimination was done by 7300 Sequence Detection Software (SDS), version 1.4 ([Figs. 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). For quality checking, 10% of the DNA samples were retested and the results were found to be 100% concordant with the previous ones.
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The genotype and allele frequencies were ascertained by direct gene count method. Chi-square test was used for establishing Hardy--Weinberg equilibrium by comparing the observed genotype frequencies with the expected genotype frequencies. Chi-square test was also applied to evaluate the differences in allele and genotype frequencies between the study population and populations of other ethnicities. Statistical analysis was performed using GraphPad InStat, version 3.06 (GraphPad Software, San Diego, CA, USA). Haploview, version 4.2 (Broad Institute of MIT and Harvard, Cambridge, MA, USA) was used for the haplotype analysis of the genes. Two-tailed *P* values were used and a *P* value less than 0.05 (*P* \< 0.05) was considered statistically significant.

Results and Discussion {#s3}
======================

Frequency distribution of SLC47A1 gene polymorphism in South Indian healthy population and comparison with other ethnicities {#s3-1}
----------------------------------------------------------------------------------------------------------------------------

The genotype frequencies were found to be in Hardy-Weinberg equilibrium (χ^2^ = 0.639). The allele and genotype frequencies of the SNP rs2289669 in *SLC47A1* gene are given in [Table 3](#T3){ref-type="table"}.

###### Allele and genotype frequencies of SNP rs2289669 in *SLC47A1* gene in healthy population

  ---------------------- ----- -------
  **Allele (n = 204)**         **%**
  A                      109   53.4
  G                      95    46.6
  Genotype (n = 102)           
  AG                     47    46.1
  AA                     31    30.4
  GG                     24    23.5
  ---------------------- ----- -------

In the studied South Indian healthy population, the major allele was "A" with a frequency of 53.4% and minor allele was "G" with a frequency of 46.6%. All other ethnicities, as reported in the NCBI database, possessed "G" and "A" as the major and minor alleles, respectively. Hence, this was a notable finding from the study ([Fig. 5](#F5){ref-type="fig"}).
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Similarly, the genotype frequencies of South Indian population were 46.1% for "AG" genotype, 30.4% for "AA" genotype, and 23.5% for "GG" genotype. Genotype and allele frequencies of South Indian population differed significantly from those of Hans Chinese in Beijing (HCB) \[*P* = 0.017\] and Japanese in Tokyo (JPT) \[*P* \< 0.001\] populations.^[@R9]^

Frequency distribution of SLC47A2 gene polymorphism in South Indian healthy population and comparison with other ethnicities {#s3-2}
----------------------------------------------------------------------------------------------------------------------------

The allele and genotype frequencies of 102 healthy volunteers with SNP rs12943590 in *SLC47A2* gene are given in [Table 4](#T4){ref-type="table"}. The "A" allele and "G" allele had a frequency of 47.5% and 52.5%, respectively. The genotype frequencies were found to be in Hardy-Weinberg equilibrium (χ^2^ = 1.409).

###### Allele and genotype frequencies of SNP rs12943590 in *SLC47A2* gene in healthy population

  ---------------------- ----- -------
  **Allele (n = 204)**         **%**
  A                      97    47.5
  G                      107   52.5
  Genotype (n = 102)           
  AG                     45    44.1
  GG                     31    30.4
  AA                     26    25.5
  ---------------------- ----- -------

The minor allele in healthy volunteers of South India was found to be "A", similar to other populations. The genotype frequencies of South Indian population were 44.1% for "AG" genotype, 30.4% for "GG" genotype, and 25.5% for "AA" genotype. Genotype and allele frequencies of South Indian population differed significantly from those of Yoruba in Ibadan, Nigeria (YRI) \[*P* \< 0.001\] and Utah residents with Northern and Western European ancestry (CEU) \[*P* = 0.005\] populations, though all these populations had "A" as the minor allele ([Fig. 6](#F6){ref-type="fig"}).^[@R10]^
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However, Stocker et al^[@R11]^ reported similar genotype frequencies viz 47.4% of "GG" genotype, 38.6% of "GA" genotype, and 14% of "AA" genotype in their healthy volunteers study samples.

The frequencies of all the studied genotypes of SNPs rs2289669 in *SLC47A1* gene and rs12943590 in *SLC47A2* gene were found to be in Hardy-Weinberg equilibrium. Therefore, it can be reaffirmed that the studied subjects are non-consanguineous and also representative of the actual population.

Haplotype analysis {#s3-3}
------------------

As both *SLC47A1* and *SLC47A2* genes are located at the same chromosome in close proximity, the likelihood of linkage disequilibrium between the SNPs (rs2289669 and rs12943590) was studied. The D' (D prime) and r^2^ (correlation coefficient) of healthy population were 0.16 and 0.021, respectively ([Fig. 7](#F7){ref-type="fig"}). This shows that chances of association between the studied SNPs are very minimal and recombination has occurred in the study populations. Thus, the haplotype analysis revealed that there was no linkage or association between two studied SNPs. Hence, the purpose of studying these SNPs is worthy though they are located contiguously in the same gene.
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Polymorphisms in these genes could result in either 'loss-of-function' or 'gain-of-function' mutations resulting in altered function of the efflux transporters. As discussed earlier, studies which explored the correlations between the glycemic response to metformin and these SNPs were reported previously in other ethnicities. Studies of Becker et al,^[@R12]^ Tkáč et al,^[@R13]^ and He et al^[@R14]^ are examples of the studies which reported significant association between the SNP rs2289669 and glycemic response. Similarly, Choi et al^[@R15]^ and Stocker et al^[@R11]^ concluded that those patients who were homozygous carriers of the minor "A" allele had a significantly poorer glycemic response than those patients with "GG/AG" genotypes in the SNP rs12943590. Whereas, trials by Klen et al^[@R16]^ and Tarasova et al^[@R17]^ did not find a significant association between the SNP rs2289669 and the metformin response.

The minor allele frequency (%) of the SNP rs2289669 in *SLC47A1* gene in other ethnic populations is as follows: African-Americans (10.4), Caucasians/European Americans (42.7 to 45.6), Chinese Americans (46.4), Japanese (37.6), and Mexican Americans (49) ([Table S1](#S1){ref-type="supplementary-material"}). The SNP rs12943590 in *SLC47A2* gene had a minor allele frequency of 27.7%, 26.2%, 48.5%, 45.8%, and 34.1% in African-Americans, Caucasians/European Americans, Chinese Americans, Koreans, and Mexican Americans populations, respectively ([Table S2](#S1){ref-type="supplementary-material"}).^[@R18]^ Umamaheswaran et al^[@R19]^ had previously studied the genetic distributions of the influx transporter, viz organic cation transporter 1 (OCT1) in South Indian population. In that study, the minor allele frequencies for the SNPs rs2282143, rs622342, and rs628031 were reported to be 8.9%, 24.5%, and 80.3%, respectively.

Conclusion {#s4}
==========

To the best of our knowledge, this study is the first of its kind to determine the allele and genotype frequencies of SNP rs2289669 in *SLC47A1* gene (MATE1) and SNP rs12943590 in *SLC47A2* gene (MATE2) in the ethnically distinct South Indian population. Hence, our study can function as a foundation for future studies to explore the association of metformin treatment response with these variants in *SLC47A1* and *SLC47A2* genes in the Dravidian South Indian population who have a characteristic genetic makeup.
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Research Highlights {#s9}
===================

What is current knowledge?√ Genetic polymorphisms in the genes coding for the efflux transporters are known to influence both the pharmacodynamics and pharmacokinetics of many drugs which act as substrates for these transporters.√ As ethnical diversity partly determines how these genes are expressed, we planned to study these SNPs in ethnically distinct South Indian (Dravidian) population.What is new here?√ The normative genotypic and allelic frequency distributions in South Indian healthy population were established. Hence, this study acts as the basis for further genetic association studies between these variants and response to drugs which utilize these transporters.√ The studied SNPs could result in either hyper-functioning ('gain-of-function') or hypo-functioning ('loss-of-function') of the concerned efflux transporter causing an attenuated or accentuated pharmacotherapeutic response, respectively.
